Platelet-mediated EMT of tumor cells is promoted by many microRNAs and other mediators released by platelets in addition to TGF-β, including prostaglandin E2 (PGE2), PDGF, and lysophosphatidic acid (LPA) (59). The gene discussed is TGFB1; the disease is neoplasm.